ibuprofen has been researched along with Parkinsonian Disorders in 7 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Standard methods were used to confirm Parkinsonism/neuroprotection." | 1.48 | Ibuprofen Protects from Cypermethrin-Induced Changes in the Striatal Dendritic Length and Spine Density. ( Bala, L; Patel, DK; Singh, A; Singh, MP; Tripathi, P, 2018) |
| "Treatment with ibuprofen or piroxicam in combination with l-dopa preserved the effect of l-dopa at the end of week 10, delayed the development of dyskinesia and decreased striatal COX-2 and VEGF levels." | 1.43 | Ibuprofen or piroxicam protects nigral neurons and delays the development of l-dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis. ( Moustafa, YM; Teema, AM; Zaitone, SA, 2016) |
| "Post treatment with ibuprofen blocked the depletion of glutathione induced by rotenone and increased the basal levels of this antioxidant in the striatum." | 1.40 | Antidepressant and antioxidative effect of Ibuprofen in the rotenone model of Parkinson's disease. ( Baggio, CH; Barbiero, JK; Bassani, TB; Gradowski, RW; Maria-Ferreira, D; Santiago, RM; Vital, MA; Zaminelli, T, 2014) |
| "Ibuprofen was shown to protect neurons against MPTP-induced injury in the striatum." | 1.39 | Potential neuroprotective effect of ibuprofen, insights from the mice model of Parkinson's disease. ( Członkowski, A; Joniec, I; Kurkowska-Jastrzębska, I; Swiątkiewicz, M; Zaremba, M, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, A | 2 |
| Tripathi, P | 2 |
| Singh, S | 1 |
| Bala, L | 1 |
| Patel, DK | 1 |
| Singh, MP | 1 |
| Corwin, C | 1 |
| Nikolopoulou, A | 1 |
| Pan, AL | 1 |
| Nunez-Santos, M | 1 |
| Vallabhajosula, S | 1 |
| Serrano, P | 1 |
| Babich, J | 1 |
| Figueiredo-Pereira, ME | 1 |
| Swiątkiewicz, M | 1 |
| Zaremba, M | 1 |
| Joniec, I | 1 |
| Członkowski, A | 2 |
| Kurkowska-Jastrzębska, I | 2 |
| Zaminelli, T | 1 |
| Gradowski, RW | 1 |
| Bassani, TB | 1 |
| Barbiero, JK | 1 |
| Santiago, RM | 1 |
| Maria-Ferreira, D | 1 |
| Baggio, CH | 1 |
| Vital, MA | 1 |
| Teema, AM | 1 |
| Zaitone, SA | 1 |
| Moustafa, YM | 1 |
| Członkowska, A | 1 |
1 review available for ibuprofen and Parkinsonian Disorders
| Article | Year |
|---|---|
Neuroinflammatory responses in Parkinson's disease: relevance of Ibuprofen in therapeutics.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Humans; Ibuprofen; Inflammation; Neu | 2021 |
6 other studies available for ibuprofen and Parkinsonian Disorders
| Article | Year |
|---|---|
Ibuprofen Protects from Cypermethrin-Induced Changes in the Striatal Dendritic Length and Spine Density.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Corpus Striatum; Dendrites; Dend | 2018 |
Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Disease Models, Animal; Enc | 2018 |
Potential neuroprotective effect of ibuprofen, insights from the mice model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Anti-Inflammatory Agents, Non-Steroidal; Basal Ganglia; Cytoprotection; Di | 2013 |
Antidepressant and antioxidative effect of Ibuprofen in the rotenone model of Parkinson's disease.
Topics: Animals; Antidepressive Agents; Antioxidants; Brain; Catalase; Depression; Dose-Response Relationshi | 2014 |
Ibuprofen or piroxicam protects nigral neurons and delays the development of l-dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dyskinesia, Drug-Induced; Female; Ibuprofen; Levod | 2016 |
Ibuprofen and the mouse model of Parkinson's disease.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Disease Models, Animal; Ibuprofen; Mice; Ne | 2006 |